Evidence map›Paper›PMID 29997992›Full record

ArticleJournal of thoracic disease2018

Secondary pulmonary alveolar proteinosis predominant in the transplanted lung in patients with idiopathic interstitial pneumonia: an autopsy case.

Satoshi Ikeda, Akimasa Sekine, Tomohisa Baba, Takuma Katano, Hideaki Yamakawa, Tsuneyuki Oda, Tae Iwasawa, Mai Matsumura, Tamiko Takemura, Takashi Ogura

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Satoshi IkedaDepartment of Respiratory Medicine, Yokohama, Kanagawa Cardiovascular and Respiratory Center, Japan.
Akimasa SekineDepartment of Respiratory Medicine, Yokohama, Kanagawa Cardiovascular and Respiratory Center, Japan.
Tomohisa BabaDepartment of Respiratory Medicine, Yokohama, Kanagawa Cardiovascular and Respiratory Center, Japan.
Takuma KatanoDepartment of Respiratory Medicine, Yokohama, Kanagawa Cardiovascular and Respiratory Center, Japan.
Hideaki YamakawaDepartment of Respiratory Medicine, Yokohama, Kanagawa Cardiovascular and Respiratory Center, Japan.
Tsuneyuki OdaDepartment of Respiratory Medicine, Yokohama, Kanagawa Cardiovascular and Respiratory Center, Japan.
Tae IwasawaDepartment of Radiology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
Mai MatsumuraDepartment of Pathology, Yokohama-city University Graduate School of Medicine, Yokohama, Japan.
Tamiko TakemuraDepartment of Pathology, Japanese Red Cross Medical Center, Tokyo, Japan.
Takashi OguraDepartment of Respiratory Medicine, Yokohama, Kanagawa Cardiovascular and Respiratory Center, Japan.
Kanagawa Cardiovascular and Respiratory Center · JPJapanese Red Cross Medical Center · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A man in his 40 s with idiopathic interstitial pneumonia underwent cadaveric left single-lung transplantation from a brain-dead donor in October 2014. In October 2015, chest high-resolution computed tomography revealed centrilobular ground-glass opacities (GGOs) predominantly in the transplanted left lung, and subsequently, the shadows progressed to a geographic GGO without crazy paving. Bronchoalveolar lavage fluid analysis revealed an opaque and milky appearance, and cytopathology demonstrated foamy alveolar macrophages and abundant granular, acellular, eosinophilic, and amorphous material in the background. There was no evidence of infection. Serum anti-granulocyte-macrophage colony-stimulating factor antibody testing was negative. We diagnosed the patient with secondary pulmonary alveolar proteinosis (PAP) following lung transplantation. Autopsy revealed PAP findings predominant in the transplanted left lung, which also had dilated lymphatic vessels. In addition to defects in alveolar macrophage function from immunosuppressive therapy, impaired lymphatic drainage due to transplantation would contribute to the onset of secondary PAP in the transplanted lung.

Indexed as

complicationslung transplantationPulmonary alveolar proteinosis (PAP)

Identifiers

PMID29997992
PMCPMC6006133
OpenAlexW2799735913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.